These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 9221772)
21. Control of extracellular dopamine at dendrite and axon terminals. Ford CP; Gantz SC; Phillips PE; Williams JT J Neurosci; 2010 May; 30(20):6975-83. PubMed ID: 20484639 [TBL] [Abstract][Full Text] [Related]
22. Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra. Cobb WS; Abercrombie ED J Neurochem; 2003 Feb; 84(3):576-84. PubMed ID: 12558977 [TBL] [Abstract][Full Text] [Related]
23. Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals. Cubeddu LX; Hoffmann IS; Talmaciu RK Ann N Y Acad Sci; 1990; 604():452-61. PubMed ID: 2171402 [TBL] [Abstract][Full Text] [Related]
24. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. Tepper JM; Sun BC; Martin LP; Creese I J Neurosci; 1997 Apr; 17(7):2519-30. PubMed ID: 9065512 [TBL] [Abstract][Full Text] [Related]
25. Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. Cragg SJ; Nicholson C; Kume-Kick J; Tao L; Rice ME J Neurophysiol; 2001 Apr; 85(4):1761-71. PubMed ID: 11287497 [TBL] [Abstract][Full Text] [Related]
26. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. Santiago M; Westerink BH Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125 [TBL] [Abstract][Full Text] [Related]
27. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation. Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539 [TBL] [Abstract][Full Text] [Related]
28. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release. Heeringa MJ; Abercrombie ED J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860 [TBL] [Abstract][Full Text] [Related]
29. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168 [TBL] [Abstract][Full Text] [Related]
30. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132 [TBL] [Abstract][Full Text] [Related]
31. Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways. Salvatore MF; Pruett BS PLoS One; 2012; 7(1):e29867. PubMed ID: 22242182 [TBL] [Abstract][Full Text] [Related]
32. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838 [TBL] [Abstract][Full Text] [Related]
33. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine. Chen NH; Reith ME J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765 [TBL] [Abstract][Full Text] [Related]
34. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Hand TH; Hu XT; Wang RY Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497 [TBL] [Abstract][Full Text] [Related]
35. Action potential and calcium dependence of tonic somatodendritic dopamine release in the Substantia Nigra pars compacta. Yee AG; Forbes B; Cheung PY; Martini A; Burrell MH; Freestone PS; Lipski J J Neurochem; 2019 Feb; 148(4):462-479. PubMed ID: 30203851 [TBL] [Abstract][Full Text] [Related]
36. I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT--DA interaction in cocaine dysfunctional behavior. Broderick PA; Phelix CF Neurosci Biobehav Rev; 1997 May; 21(3):227-60. PubMed ID: 9168262 [TBL] [Abstract][Full Text] [Related]
37. Subcellular localization of D2 receptors in the murine substantia nigra. Lebowitz JJ; Trinkle M; Bunzow JR; Balcita-Pedicino JJ; Hetelekides S; Robinson B; De La Torre S; Aicher SA; Sesack SR; Williams JT Brain Struct Funct; 2022 Apr; 227(3):925-941. PubMed ID: 34854963 [TBL] [Abstract][Full Text] [Related]
38. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent. Cobb WS; Abercrombie ED Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698 [TBL] [Abstract][Full Text] [Related]
39. Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse. Bernardini GL; Gu X; Viscardi E; German DC J Neural Transm Gen Sect; 1991; 84(3):183-93. PubMed ID: 1679335 [TBL] [Abstract][Full Text] [Related]
40. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Beckstead RM Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]